Versican proteolysis as a key regulator of CD8+ T-cell infiltration in colorectal cancer.

Dustin A. Deming,Chelsea Hope,Philip B. Emmerich,Adam Pagenkopf,Kristina A. Matkowskyj,Dana Van DeHey,Susan N. Payne,Linda Clipson,Natalie S. Callander,Peiman Hematti,Shigeki Miyamoto,Michael G. Johnson,Fotis Asimakopoulos

Versican proteolysis as a key regulator of CD8+ T-cell infiltration in colorectal cancer.

2017

Dustin A. Deming
Chelsea Hope
Philip B. Emmerich
Adam Pagenkopf
Kristina A. Matkowskyj
Dana Van DeHey
Susan N. Payne
Linda Clipson
Natalie S. Callander
Peiman Hematti
Shigeki Miyamoto
Michael G. Johnson
Fotis Asimakopoulos

e15082Background: Colorectal cancer (CRC) originates within immunologically complex microenvironments. To date the benefits of immunotherapy have been modest except in neoantigen-laden mismatch rep...

Keywords:

Versican
Cancer research
Pathology
Cytotoxic T cell
Colorectal cancer
Regulator
Proteolysis
Medicine
Immunotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations